Skip to main content

Table 7 FACT-B SWB scores at each post-treatment visit and changes from baseline (final analysis set)

From: Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study

  

Final analysis set (N = 486)

Visit

Clinical efficacy

Total score

Change from baseline in total score

Baseline

N (missing)

486 (0)

 
 

Mean (SD)

18.61 (6.732)

 
 

Median

19.30

 
 

Min–max

0.0–28.0

 

6 months

N (missing)

480 (6)

480 (6)

 

Mean (SD)

19.14 (6.068)

0.54 (5.872)

 

Median

19.83

0.00

 

Min–max

0.0–28.0

−24.5 to 28.0

 

P value in comparison to baseline

 

.0435

12 months

N (missing)

483 (3)

483 (3)

 

Mean (SD)

19.35 (6.531)

0.75 (6.245)

 

Median

20.00

0.00

 

Min–max

0.0–28.0

−21.3 to 28.0

 

P value in comparison to baseline

 

.0086

18 months

N (missing)

447 (39)

447 (39)

 

Mean (SD)

18.32 (6.900)

−0.45 (6.605)

 

Median

19.00

0.00

 

Min–max

0.0–28.0

−20.0 to 28.0

 

P value in comparison to baseline

 

0.1523

24 months

N (missing)

436 (50)

436 (50)

 

Mean (SD)

18.40 (7.422)

−0.19 (6.961)

 

Median

19.83

0.00

 

Min–max

1.0–28.0

−21.0 to 28.0

 

P value in comparison to baseline

 

0.5677

  1. FACT-B Functional Assessment of Cancer Therapy-Breast, SD standard deviation, SWB social well-being